APRE

SEC source: 0001104659-26-075279 · tm2618211-2_4seq1.xml · derivative · entry 3

Pamukcu Rifat · CIK 0001929298 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,555

Underlying: Common Stock · 12,555 shares

Expires 2036-06-16

F3 · derivative.exercise_date: The option vests in full on June 16, 2027, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

SEC source: 0001104659-26-075279 · tm2618211-2_4seq1.xml · nonDerivative · entry 1

Pamukcu Rifat · CIK 0001929298 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,581

F1 · shares: These shares represent restricted stock units which were granted on June 16, 2026, and which will vest and be settled in common stock on June 16, 2027, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

SEC source: 0001104659-26-075280 · tm2618211-3_4seq1.xml · derivative · entry 3

Duey Marc · CIK 0001925150 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,555

Underlying: Common Stock · 12,555 shares

Expires 2036-06-16

F3 · derivative.exercise_date: The option vests in full on June 16, 2027, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

SEC source: 0001104659-26-075280 · tm2618211-3_4seq1.xml · nonDerivative · entry 1

Duey Marc · CIK 0001925150 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 259,290

F1 · shares: These shares represent restricted stock units which were granted on June 16, 2026, and which will vest and be settled in common stock on June 16, 2027, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

SEC source: 0001104659-26-075284 · tm2618211-7_4seq1.xml · derivative · entry 2

Gruia Gabriela · CIK 0001860326 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,555

Underlying: Common Stock · 12,555 shares

Expires 2036-06-16

F2 · derivative.exercise_date: The option vests in full on June 16, 2027, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

SEC source: 0001104659-26-075284 · tm2618211-7_4seq1.xml · nonDerivative · entry 1

Gruia Gabriela · CIK 0001860326 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,180

F1 · shares: These shares represent restricted stock units which were granted on June 16, 2026, and which will vest and be settled in common stock on June 16, 2027, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

SEC source: 0001104659-26-075286 · tm2618211-8_4seq1.xml · derivative · entry 2

Grissinger Michael · CIK 0001757601 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,555

Underlying: Common Stock · 12,555 shares

Expires 2036-06-16

F2 · derivative.exercise_date: The option vests in full on June 16, 2027, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

SEC source: 0001104659-26-075286 · tm2618211-8_4seq1.xml · nonDerivative · entry 1

Grissinger Michael · CIK 0001757601 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,024

F1 · shares: These shares represent restricted stock units which were granted on June 16, 2026, and which will vest and be settled in common stock on June 16, 2027, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

SEC source: 0001104659-26-075282 · tm2618211-5_4seq1.xml · derivative · entry 2

HENNEMAN JOHN B III · CIK 0001187572 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,555

Underlying: Common Stock · 12,555 shares

Expires 2036-06-16

F2 · derivative.exercise_date: The option vests in full on June 16, 2027, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

SEC source: 0001104659-26-075282 · tm2618211-5_4seq1.xml · nonDerivative · entry 1

HENNEMAN JOHN B III · CIK 0001187572 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,364

F1 · shares: These shares represent restricted stock units which were granted on June 16, 2026, and which will vest and be settled in common stock on June 16, 2027, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

SEC source: 0001104659-26-075281 · tm2618211-4_4seq1.xml · derivative · entry 2

BIZZARI JEAN-PIERRE · CIK 0001630914 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,555

Underlying: Common Stock · 12,555 shares

Expires 2036-06-16

F2 · derivative.exercise_date: The option vests in full on June 16, 2027, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

SEC source: 0001104659-26-075281 · tm2618211-4_4seq1.xml · nonDerivative · entry 1

BIZZARI JEAN-PIERRE · CIK 0001630914 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,180

F1 · shares: These shares represent restricted stock units which were granted on June 16, 2026, and which will vest and be settled in common stock on June 16, 2027, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

SEC source: 0001104659-26-075283 · tm2618211-6_4seq1.xml · derivative · entry 2

Peters Richard · CIK 0001697628 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,555

Underlying: Common Stock · 12,555 shares

Expires 2036-06-16

F2 · derivative.exercise_date: The option vests in full on June 16, 2027, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

SEC source: 0001104659-26-075283 · tm2618211-6_4seq1.xml · nonDerivative · entry 1

Peters Richard · CIK 0001697628 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,254

F1 · shares: These shares represent restricted stock units which were granted on June 16, 2026, and which will vest and be settled in common stock on June 16, 2027, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

SEC source: 0001104659-26-075278 · tm2618211-1_4seq1.xml · derivative · entry 2

Seizinger Bernd R. · CIK 0001789042 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,555

Underlying: Common Stock · 12,555 shares

Expires 2036-06-16

F2 · derivative.exercise_date: The option vests in full on June 16, 2027, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

SEC source: 0001104659-26-075278 · tm2618211-1_4seq1.xml · nonDerivative · entry 1

Seizinger Bernd R. · CIK 0001789042 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,910

F1 · shares: These shares represent restricted stock units which were granted on June 16, 2026, and which will vest and be settled in common stock on June 16, 2027, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

SEC source: 0001104659-26-038518 · tm2610878-1_4seq1.xml · derivative · entry 2

Peters Richard · CIK 0001697628 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 123,915

Underlying: Common Stock · 123,915 shares

Expires not disclosed

F1 · security: On March 30, 2026, the Issuer entered into a securities purchase agreement (the "Purchase Agreement") with certain accredited investors, including the Reporting Person. Pursuant to the terms of the Purchase Agreement, the Issuer issued and sold to the Reporting Person in a private placement which closed on March 31, 2026, (i) pre-funded warrants ("Pre-Funded Warrants") to purchase up to an aggregate of 123,915 shares of the Issuer's common stock ("Shares") at a purchase price of $0.808, less the $0.001 exercise price, per Pre-Funded Warrant and (ii) accompanying common warrants ("Common Warrants") to purchase up to an aggregate of 123,915 Shares.

F1 · price: On March 30, 2026, the Issuer entered into a securities purchase agreement (the "Purchase Agreement") with certain accredited investors, including the Reporting Person. Pursuant to the terms of the Purchase Agreement, the Issuer issued and sold to the Reporting Person in a private placement which closed on March 31, 2026, (i) pre-funded warrants ("Pre-Funded Warrants") to purchase up to an aggregate of 123,915 shares of the Issuer's common stock ("Shares") at a purchase price of $0.808, less the $0.001 exercise price, per Pre-Funded Warrant and (ii) accompanying common warrants ("Common Warrants") to purchase up to an aggregate of 123,915 Shares.

F3 · derivative.expiration_date: The Common Warrants are immediately exercisable, subject to the Beneficial Ownership Limitation. The Common Warrants will expire on the earlier of (ii) December 31, 2029, and (ii) 30 calendars days after the date upon which the Pre-Funded Warrant is exercised, proportional to the amount of such exercise.

SEC source: 0001104659-26-038518 · tm2610878-1_4seq1.xml · derivative · entry 1

Peters Richard · CIK 0001697628 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 123,915

Underlying: Common Stock · 123,915 shares

Expires not disclosed

F1 · security: On March 30, 2026, the Issuer entered into a securities purchase agreement (the "Purchase Agreement") with certain accredited investors, including the Reporting Person. Pursuant to the terms of the Purchase Agreement, the Issuer issued and sold to the Reporting Person in a private placement which closed on March 31, 2026, (i) pre-funded warrants ("Pre-Funded Warrants") to purchase up to an aggregate of 123,915 shares of the Issuer's common stock ("Shares") at a purchase price of $0.808, less the $0.001 exercise price, per Pre-Funded Warrant and (ii) accompanying common warrants ("Common Warrants") to purchase up to an aggregate of 123,915 Shares.

F2 · derivative.expiration_date: The Pre-Funded Warrants are immediately exercisable at any time after the date of issuance. Pursuant to the terms of the Pre-Funded Warrants, the Pre-Funded Warrants cannot be exercised to the extent that, upon giving effect to or immediately prior to such exercise, would cause either (i) the aggregate number of shares of Common Stock beneficially owned by such holder (together with its affiliates) would exceed 4.99% of the number of shares of Common Stock outstanding immediately after giving effect to such exercise or (ii) the combined voting power of the Issuer's securities beneficially owned by such holder (together with its affiliates) would exceed 9.99% of the combined voting power of all of the Issuer's securities outstanding immediately after giving effect to the exercise (the "Beneficial Ownership Limitation")

SEC source: 0001104659-26-038522 · tm2610878-2_4seq1.xml · derivative · entry 2

Hamill John P. · CIK 0001716213 · SrVP/CFO/Prin Fin & Acct Ofcr

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,978

Underlying: Common Stock · 30,978 shares

Expires not disclosed

F1 · security: On March 30, 2026, the Issuer entered into a securities purchase agreement (the "Purchase Agreement") with certain accredited investors, including the Reporting Person. Pursuant to the terms of the Purchase Agreement, the Issuer issued and sold to the Reporting Person in a private placement which closed on March 31, 2026, (i) pre-funded warrants ("Pre-Funded Warrants") to purchase up to an aggregate of 30,978 shares of the Issuer's common stock ("Shares") at a purchase price of $0.808, less the $0.001 exercise price, per Pre-Funded Warrant and (ii) accompanying common warrants ("Common Warrants") to purchase up to an aggregate of 30,978 Shares.

F1 · price: On March 30, 2026, the Issuer entered into a securities purchase agreement (the "Purchase Agreement") with certain accredited investors, including the Reporting Person. Pursuant to the terms of the Purchase Agreement, the Issuer issued and sold to the Reporting Person in a private placement which closed on March 31, 2026, (i) pre-funded warrants ("Pre-Funded Warrants") to purchase up to an aggregate of 30,978 shares of the Issuer's common stock ("Shares") at a purchase price of $0.808, less the $0.001 exercise price, per Pre-Funded Warrant and (ii) accompanying common warrants ("Common Warrants") to purchase up to an aggregate of 30,978 Shares.

F3 · derivative.expiration_date: The Common Warrants are immediately exercisable, subject to the Beneficial Ownership Limitation. The Common Warrants will expire on the earlier of (ii) December 31, 2029, and (ii) 30 calendars days after the date upon which the Pre-Funded Warrant is exercised, proportional to the amount of such exercise.

SEC source: 0001104659-26-038522 · tm2610878-2_4seq1.xml · derivative · entry 1

Hamill John P. · CIK 0001716213 · SrVP/CFO/Prin Fin & Acct Ofcr

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,978

Underlying: Common Stock · 30,978 shares

Expires not disclosed

F1 · security: On March 30, 2026, the Issuer entered into a securities purchase agreement (the "Purchase Agreement") with certain accredited investors, including the Reporting Person. Pursuant to the terms of the Purchase Agreement, the Issuer issued and sold to the Reporting Person in a private placement which closed on March 31, 2026, (i) pre-funded warrants ("Pre-Funded Warrants") to purchase up to an aggregate of 30,978 shares of the Issuer's common stock ("Shares") at a purchase price of $0.808, less the $0.001 exercise price, per Pre-Funded Warrant and (ii) accompanying common warrants ("Common Warrants") to purchase up to an aggregate of 30,978 Shares.

F2 · derivative.expiration_date: The Pre-Funded Warrants are immediately exercisable at any time after the date of issuance. Pursuant to the terms of the Pre-Funded Warrants, the Pre-Funded Warrants cannot be exercised to the extent that, upon giving effect to or immediately prior to such exercise, would cause either (i) the aggregate number of shares of Common Stock beneficially owned by such holder (together with its affiliates) would exceed 4.99% of the number of shares of Common Stock outstanding immediately after giving effect to such exercise or (ii) the combined voting power of the Issuer's securities beneficially owned by such holder (together with its affiliates) would exceed 9.99% of the combined voting power of all of the Issuer's securities outstanding immediately after giving effect to the exercise (the "Beneficial Ownership Limitation")

SEC source: 0001104659-26-028656 · tm268953-2_4seq1.xml · derivative · entry 4

Gilad Oren · CIK 0001929300 · Director · President/CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,700

Underlying: Common Stock · 80,700 shares

Expires 2036-03-12

F3 · derivative.exercise_date: Twenty-five percent of these options vest on March 12, 2027, with the remaining options vesting ratably over the following 36 months, subject to the reporting person's continued employment through and including the applicable vesting dates and subject to acceleration under certain conditions.

SEC source: 0001104659-26-028656 · tm268953-2_4seq1.xml · nonDerivative · entry 1

Gilad Oren · CIK 0001929300 · Director · President/CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 393,895

F1 · shares: These shares represent restricted stock units and shall vest and be settled in the Issuer's common stock in three (3) equal annual installments beginning on March 12, 2027, until vested in full, subject to the reporting person's continued employment through and including the applicable vesting dates and subject to acceleration under certain conditions.

SEC source: 0001104659-26-028653 · tm268953-1_4seq1.xml · derivative · entry 2

Hamill John P. · CIK 0001716213 · SrVP/CFO/Prin Fin & Acct Ofcr

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,380

Underlying: Common Stock · 40,380 shares

Expires 2036-03-12

F2 · derivative.exercise_date: Twenty-five percent of these options vest on March 12, 2027, with the remaining options vesting ratably over the following 36 months, subject to the reporting person's continued employment through and including the applicable vesting dates and subject to acceleration under certain conditions.

SEC source: 0001104659-26-028653 · tm268953-1_4seq1.xml · nonDerivative · entry 1

Hamill John P. · CIK 0001716213 · SrVP/CFO/Prin Fin & Acct Ofcr

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,528

F1 · shares: These shares represent restricted stock units and shall vest and be settled in the Issuer's common stock in three (3) equal annual installments beginning on March 12, 2027, until vested in full, subject to the reporting person's continued employment through and including the applicable vesting dates and subject to acceleration under certain conditions.

SEC source: 0001104659-26-009206 · tm264801-2_4seq1.xml · derivative · entry 4

Gilad Oren · CIK 0001929300 · Director · President/CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,100

Underlying: Common Stock · 28,100 shares

Expires not disclosed

F3 · price: The Common Warrants are immediately exercisable, provided, that, the Common Warrants cannot be exercised to the extent that, upon giving effect to or immediately prior to such exercise, would cause either (i) the aggregate number of shares of Common Stock beneficially owned by such holder (together with its affiliates) would exceed 4.99% of the number of shares of Common Stock outstanding immediately after giving effect to such exercise or (ii) the combined voting power of the Issuer's securities beneficially owned by such holder (together with its affiliates) would exceed 9.99% of the combined voting power of all of the Issuer's securities outstanding immediately after giving effect to the exercise.

F4 · price: The Common Warrants will expire on or prior to 5:00 p.m. (New York City time) on the second year anniversary of the earlier of: (i) the effective date of the registration statement registering the underlying Shares of the Common Warrants and (ii) the date the Shares underlying the Common Warrants are eligible for sale under Rule 144 (assuming cashless exercise of the Common Warrants) without the requirement for the Issuer to be in compliance with the current public information required under Rule 144.

F3 · derivative.expiration_date: The Common Warrants are immediately exercisable, provided, that, the Common Warrants cannot be exercised to the extent that, upon giving effect to or immediately prior to such exercise, would cause either (i) the aggregate number of shares of Common Stock beneficially owned by such holder (together with its affiliates) would exceed 4.99% of the number of shares of Common Stock outstanding immediately after giving effect to such exercise or (ii) the combined voting power of the Issuer's securities beneficially owned by such holder (together with its affiliates) would exceed 9.99% of the combined voting power of all of the Issuer's securities outstanding immediately after giving effect to the exercise.

F4 · derivative.expiration_date: The Common Warrants will expire on or prior to 5:00 p.m. (New York City time) on the second year anniversary of the earlier of: (i) the effective date of the registration statement registering the underlying Shares of the Common Warrants and (ii) the date the Shares underlying the Common Warrants are eligible for sale under Rule 144 (assuming cashless exercise of the Common Warrants) without the requirement for the Issuer to be in compliance with the current public information required under Rule 144.

SEC source: 0001104659-26-009206 · tm264801-2_4seq1.xml · nonDerivative · entry 1

Gilad Oren · CIK 0001929300 · Director · President/CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 373,720

F2 · shares: On January 28, 2026, the Issuer entered into a securities purchase agreement with certain accredited investors, including the Reporting Person. Pursuant to the terms of the Purchase Agreement, the Issuer issued and sold to the Reporting Person in a private placement, which closed on January 30, 2026, an aggregate of 28,100 shares of the Issuer's common stock (the "Shares") at a purchase price of $0.89 per Share. The Reporting Person also received accompanying common warrants (the "Common Warrants") to purchase up to an aggregate of 28,100 Shares.

SEC source: 0001104659-26-009203 · tm264801-1_4seq1.xml · derivative · entry 2

Hamill John P. · CIK 0001716213 · SrVP/CFO/Prin Fin & Acct Ofcr

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,700

Underlying: Common Stock · 5,700 shares

Expires not disclosed

F2 · price: The Common Warrants are immediately exercisable, provided, that, the Common Warrants cannot be exercised to the extent that, upon giving effect to or immediately prior to such exercise, would cause either (i) the aggregate number of shares of Common Stock beneficially owned by such holder (together with its affiliates) would exceed 4.99% of the number of shares of Common Stock outstanding immediately after giving effect to such exercise or (ii) the combined voting power of the Issuer's securities beneficially owned by such holder (together with its affiliates) would exceed 9.99% of the combined voting power of all of the Issuer's securities outstanding immediately after giving effect to the exercise.

F3 · price: The Common Warrants will expire on or prior to 5:00 p.m. (New York City time) on the second year anniversary of the earlier of: (i) the effective date of the registration statement registering the underlying Shares of the Common Warrants and (ii) the date the Shares underlying the Common Warrants are eligible for sale under Rule 144 (assuming cashless exercise of the Common Warrants) without the requirement for the Issuer to be in compliance with the current public information required under Rule 144.

F2 · derivative.expiration_date: The Common Warrants are immediately exercisable, provided, that, the Common Warrants cannot be exercised to the extent that, upon giving effect to or immediately prior to such exercise, would cause either (i) the aggregate number of shares of Common Stock beneficially owned by such holder (together with its affiliates) would exceed 4.99% of the number of shares of Common Stock outstanding immediately after giving effect to such exercise or (ii) the combined voting power of the Issuer's securities beneficially owned by such holder (together with its affiliates) would exceed 9.99% of the combined voting power of all of the Issuer's securities outstanding immediately after giving effect to the exercise.

F3 · derivative.expiration_date: The Common Warrants will expire on or prior to 5:00 p.m. (New York City time) on the second year anniversary of the earlier of: (i) the effective date of the registration statement registering the underlying Shares of the Common Warrants and (ii) the date the Shares underlying the Common Warrants are eligible for sale under Rule 144 (assuming cashless exercise of the Common Warrants) without the requirement for the Issuer to be in compliance with the current public information required under Rule 144.

SEC source: 0001104659-26-009203 · tm264801-1_4seq1.xml · nonDerivative · entry 1

Hamill John P. · CIK 0001716213 · SrVP/CFO/Prin Fin & Acct Ofcr

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,433

F1 · shares: On January 28, 2026, the Issuer entered into a securities purchase agreement with certain accredited investors, including the Reporting Person. Pursuant to the terms of the Purchase Agreement, the Issuer issued and sold to the Reporting Person in a private placement, which closed on January 30, 2026, an aggregate of 5,700 shares of the Issuer's common stock (the "Shares") at a purchase price of $0.89 per Share. The Reporting Person also received accompanying common warrants (the "Common Warrants") to purchase up to an aggregate of 5,700 Shares.

SEC source: 0001104659-25-120152 · tm2533219-1_4seq1.xml · derivative · entry 5

Gilad Oren · CIK 0001929300 · Director · President/CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,459

Underlying: Common Stock · 21,459 shares

Expires not disclosed

F2 · security: On December 8, 2025, the Issuer entered into a securities purchase agreement with certain accredited investors, including the Reporting Person. Pursuant to the terms of the Purchase Agreement, the Issuer issued and sold to the Reporting Person in a private placement which closed on December 10, 2025 pre-funded warrants ("Pre-Funded Warrants") to purchase an aggregate of 21,459 shares of the Issuer's common stock ("Shares") at a purchase price of $1.165 per Pre-Funded Warrant. The Reporting Person also received accompanying common warrants ("Common Warrants") to purchase up to an aggregate of 21,459 Shares.

F4 · price: The Common Warrants are immediately exercisable, subject to the Beneficial Ownership Limitation. The Common Warrants will expire on or prior to 5:00 p.m. (New York City time) on the fifth year anniversary of the earlier of: (i) the effective date of the registration statement registering the underlying Shares of the Common Warrants and (ii) the date the Shares underlying the Common Warrants are eligible for sale under Rule 144 (assuming cashless exercise of the Common Warrants) without the requirement for the Issuer to be in compliance with the current public information required under Rule 144.

F4 · derivative.expiration_date: The Common Warrants are immediately exercisable, subject to the Beneficial Ownership Limitation. The Common Warrants will expire on or prior to 5:00 p.m. (New York City time) on the fifth year anniversary of the earlier of: (i) the effective date of the registration statement registering the underlying Shares of the Common Warrants and (ii) the date the Shares underlying the Common Warrants are eligible for sale under Rule 144 (assuming cashless exercise of the Common Warrants) without the requirement for the Issuer to be in compliance with the current public information required under Rule 144.

SEC source: 0001104659-25-120152 · tm2533219-1_4seq1.xml · derivative · entry 4

Gilad Oren · CIK 0001929300 · Director · President/CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,459

Underlying: Common Stock · 21,459 shares

Expires not disclosed

F2 · security: On December 8, 2025, the Issuer entered into a securities purchase agreement with certain accredited investors, including the Reporting Person. Pursuant to the terms of the Purchase Agreement, the Issuer issued and sold to the Reporting Person in a private placement which closed on December 10, 2025 pre-funded warrants ("Pre-Funded Warrants") to purchase an aggregate of 21,459 shares of the Issuer's common stock ("Shares") at a purchase price of $1.165 per Pre-Funded Warrant. The Reporting Person also received accompanying common warrants ("Common Warrants") to purchase up to an aggregate of 21,459 Shares.

F3 · derivative.expiration_date: The Pre-Funded Warrants are immediately exercisable at any time after the date of issuance. Pursuant to the terms of the Pre-Funded Warrants, the Pre-Funded Warrants cannot be exercised to the extent that, upon giving effect to or immediately prior to such exercise, would cause either (i) the aggregate number of shares of Common Stock beneficially owned by such holder (together with its affiliates) would exceed 4.99% of the number of shares of Common Stock outstanding immediately after giving effect to such exercise or (ii) the combined voting power of the Issuer's securities beneficially owned by such holder (together with its affiliates) would exceed 9.99% of the combined voting power of all of the Issuer's securities outstanding immediately after giving effect to the exercise (the "Beneficial Ownership Limitation")

SEC source: 0001104659-25-120156 · tm2533219-3_4seq1.xml · derivative · entry 3

Duey Marc · CIK 0001925150 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,459

Underlying: Common Stock · 21,459 shares

Expires not disclosed

F3 · price: The Common Warrants are immediately exercisable, provided, that, the Common Warrants cannot be exercised to the extent that, upon giving effect to or immediately prior to such exercise, would cause either (i) the aggregate number of shares of Common Stock beneficially owned by such holder (together with its affiliates) would exceed 4.99% of the number of shares of Common Stock outstanding immediately after giving effect to such exercise or (ii) the combined voting power of the Issuer's securities beneficially owned by such holder (together with its affiliates) would exceed 9.99% of the combined voting power of all of the Issuer's securities outstanding immediately after giving effect to the exercise.

F4 · price: The Common Warrants will expire on or prior to 5:00 p.m. (New York City time) on the fifth year anniversary of the earlier of: (i) the effective date of the registration statement registering the underlying Shares of the Common Warrants and (ii) the date the Shares underlying the Common Warrants are eligible for sale under Rule 144 (assuming cashless exercise of the Common Warrants) without the requirement for the Issuer to be in compliance with the current public information required under Rule 144.

F3 · derivative.expiration_date: The Common Warrants are immediately exercisable, provided, that, the Common Warrants cannot be exercised to the extent that, upon giving effect to or immediately prior to such exercise, would cause either (i) the aggregate number of shares of Common Stock beneficially owned by such holder (together with its affiliates) would exceed 4.99% of the number of shares of Common Stock outstanding immediately after giving effect to such exercise or (ii) the combined voting power of the Issuer's securities beneficially owned by such holder (together with its affiliates) would exceed 9.99% of the combined voting power of all of the Issuer's securities outstanding immediately after giving effect to the exercise.

F4 · derivative.expiration_date: The Common Warrants will expire on or prior to 5:00 p.m. (New York City time) on the fifth year anniversary of the earlier of: (i) the effective date of the registration statement registering the underlying Shares of the Common Warrants and (ii) the date the Shares underlying the Common Warrants are eligible for sale under Rule 144 (assuming cashless exercise of the Common Warrants) without the requirement for the Issuer to be in compliance with the current public information required under Rule 144.

SEC source: 0001104659-25-120156 · tm2533219-3_4seq1.xml · nonDerivative · entry 1

Duey Marc · CIK 0001925150 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 256,155

F1 · shares: On December 8, 2025, the Issuer entered into a securities purchase agreement with certain accredited investors, including the Reporting Person. Pursuant to the terms of the Purchase Agreement, the Issuer issued and sold to the Reporting Person in a private placement which closed on December 10, 2025 an aggregate of 21,459 shares of the Issuer's common stock ("Shares") at a purchase price of $1.165. The Reporting Person also received accompanying common warrants ("Common Warrants") to purchase up to an aggregate of 21,459 Shares.

SEC source: 0001104659-25-120155 · tm2533219-2_4seq1.xml · derivative · entry 2

Hamill John P. · CIK 0001716213 · SrVP/CFO/Prin Fin & Acct Ofcr

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires not disclosed

F2 · price: The Common Warrants are immediately exercisable, provided, that, the Common Warrants cannot be exercised to the extent that, upon giving effect to or immediately prior to such exercise, would cause either (i) the aggregate number of shares of Common Stock beneficially owned by such holder (together with its affiliates) would exceed 4.99% of the number of shares of Common Stock outstanding immediately after giving effect to such exercise or (ii) the combined voting power of the Issuer's securities beneficially owned by such holder (together with its affiliates) would exceed 9.99% of the combined voting power of all of the Issuer's securities outstanding immediately after giving effect to the exercise.

F3 · price: The Common Warrants will expire on or prior to 5:00 p.m. (New York City time) on the fifth year anniversary of the earlier of: (i) the effective date of the registration statement registering the underlying Shares of the Common Warrants and (ii) the date the Shares underlying the Common Warrants are eligible for sale under Rule 144 (assuming cashless exercise of the Common Warrants) without the requirement for the Issuer to be in compliance with the current public information required under Rule 144.

F2 · derivative.expiration_date: The Common Warrants are immediately exercisable, provided, that, the Common Warrants cannot be exercised to the extent that, upon giving effect to or immediately prior to such exercise, would cause either (i) the aggregate number of shares of Common Stock beneficially owned by such holder (together with its affiliates) would exceed 4.99% of the number of shares of Common Stock outstanding immediately after giving effect to such exercise or (ii) the combined voting power of the Issuer's securities beneficially owned by such holder (together with its affiliates) would exceed 9.99% of the combined voting power of all of the Issuer's securities outstanding immediately after giving effect to the exercise.

F3 · derivative.expiration_date: The Common Warrants will expire on or prior to 5:00 p.m. (New York City time) on the fifth year anniversary of the earlier of: (i) the effective date of the registration statement registering the underlying Shares of the Common Warrants and (ii) the date the Shares underlying the Common Warrants are eligible for sale under Rule 144 (assuming cashless exercise of the Common Warrants) without the requirement for the Issuer to be in compliance with the current public information required under Rule 144.

SEC source: 0001104659-25-120155 · tm2533219-2_4seq1.xml · nonDerivative · entry 1

Hamill John P. · CIK 0001716213 · SrVP/CFO/Prin Fin & Acct Ofcr

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,733

F1 · shares: On December 8, 2025, the Issuer entered into a securities purchase agreement with certain accredited investors, including the Reporting Person. Pursuant to the terms of the Purchase Agreement, the Issuer issued and sold to the Reporting Person in a private placement which closed on December 10, 2025 an aggregate of 5,000 shares of the Issuer's common stock ("Shares") at a purchase price of $1.165. The Reporting Person also received accompanying common warrants ("Common Warrants") to purchase up to an aggregate of 5,000 Shares.

SEC source: 0001104659-25-057818 · tm2517366-6_4seq1.xml · derivative · entry 3

Pamukcu Rifat · CIK 0001929298 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,185

Underlying: Common Stock · 4,185 shares

Expires 2035-06-05

F3 · derivative.exercise_date: The option vests in full on June 5, 2026, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

SEC source: 0001104659-25-057818 · tm2517366-6_4seq1.xml · nonDerivative · entry 1

Pamukcu Rifat · CIK 0001929298 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,446

F1 · shares: These shares represent restricted stock units which were granted on June 5, 2025, and which will vest and be settled in common stock on June 5, 2026, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

SEC source: 0001104659-25-057809 · tm2517366-2_4seq1.xml · derivative · entry 3

Duey Marc · CIK 0001925150 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,185

Underlying: Common Stock · 4,185 shares

Expires 2035-06-05

F3 · derivative.exercise_date: The option vests in full on June 5, 2026, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

SEC source: 0001104659-25-057809 · tm2517366-2_4seq1.xml · nonDerivative · entry 1

Duey Marc · CIK 0001925150 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 234,696

F1 · shares: These shares represent restricted stock units which were granted on June 5, 2025, and which will vest and be settled in common stock on June 5, 2026, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

SEC source: 0001104659-25-057813 · tm2517366-4_4seq1.xml · derivative · entry 2

Gruia Gabriela · CIK 0001860326 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,185

Underlying: Common Stock · 4,185 shares

Expires 2035-06-05

F2 · derivative.exercise_date: The option vests in full on June 5, 2026, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

SEC source: 0001104659-25-057813 · tm2517366-4_4seq1.xml · nonDerivative · entry 1

Gruia Gabriela · CIK 0001860326 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,045

F1 · shares: These shares represent restricted stock units which were granted on June 5, 2025, and which will vest and be settled in common stock on June 5, 2026, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

SEC source: 0001104659-25-057811 · tm2517366-3_4seq1.xml · derivative · entry 2

Grissinger Michael · CIK 0001757601 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,185

Underlying: Common Stock · 4,185 shares

Expires 2035-06-05

F2 · derivative.exercise_date: The option vests in full on June 5, 2026, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

SEC source: 0001104659-25-057811 · tm2517366-3_4seq1.xml · nonDerivative · entry 1

Grissinger Michael · CIK 0001757601 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,889

F1 · shares: These shares represent restricted stock units which were granted on June 5, 2025, and which will vest and be settled in common stock on June 5, 2026, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

SEC source: 0001104659-25-057815 · tm2517366-5_4seq1.xml · derivative · entry 2

HENNEMAN JOHN B III · CIK 0001187572 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,185

Underlying: Common Stock · 4,185 shares

Expires 2035-06-05

F2 · derivative.exercise_date: The option vests in full on June 5, 2026, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

SEC source: 0001104659-25-057815 · tm2517366-5_4seq1.xml · nonDerivative · entry 1

HENNEMAN JOHN B III · CIK 0001187572 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,229

F1 · shares: These shares represent restricted stock units which were granted on June 5, 2025, and which will vest and be settled in common stock on June 5, 2026, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

SEC source: 0001104659-25-057806 · tm2517366-1_4seq1.xml · derivative · entry 2

BIZZARI JEAN-PIERRE · CIK 0001630914 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,185

Underlying: Common Stock · 4,185 shares

Expires 2035-06-05

F2 · derivative.exercise_date: The option vests in full on June 5, 2026, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

SEC source: 0001104659-25-057806 · tm2517366-1_4seq1.xml · nonDerivative · entry 1

BIZZARI JEAN-PIERRE · CIK 0001630914 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,045

F1 · shares: These shares represent restricted stock units which were granted on June 5, 2025, and which will vest and be settled in common stock on June 5, 2026, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

SEC source: 0001104659-25-057821 · tm2517366-7_4seq1.xml · derivative · entry 2

Peters Richard · CIK 0001697628 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,185

Underlying: Common Stock · 4,185 shares

Expires 2035-06-05

F2 · derivative.exercise_date: The option vests in full on June 5, 2026, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

SEC source: 0001104659-25-057821 · tm2517366-7_4seq1.xml · nonDerivative · entry 1

Peters Richard · CIK 0001697628 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,119

F1 · shares: These shares represent restricted stock units which were granted on June 5, 2025, and which will vest and be settled in common stock on June 5, 2026, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

SEC source: 0001104659-25-057823 · tm2517366-8_4seq1.xml · derivative · entry 2

Seizinger Bernd R. · CIK 0001789042 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,185

Underlying: Common Stock · 4,185 shares

Expires 2035-06-05

F2 · derivative.exercise_date: The option vests in full on June 5, 2026, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

SEC source: 0001104659-25-057823 · tm2517366-8_4seq1.xml · nonDerivative · entry 1

Seizinger Bernd R. · CIK 0001789042 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,775

F1 · shares: These shares represent restricted stock units which were granted on June 5, 2025, and which will vest and be settled in common stock on June 5, 2026, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.